Exosome miR-223-3p in the bone marrow-derived mesenchymal stem cells alleviates the inflammation and airway remodeling through NLRP3-induced ASC/Caspase-1/GSDMD signaling pathway
International Immunopharmacology · 2023-10 · 123 · 110746
DOI: 10.1016/j.intimp.2023.110746 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023-10. Verfasst von Xiang Li und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, China. Hauptthemen laut MEDLINE: Asthma, Exosomes, Mesenchymal Stem Cells, MicroRNAs. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
Asthma is one of the most common chronic respiratory diseases in the world. Exploration and understanding of the pathogenesis of epithelial-mesenchymal transition in airway epithelial cells, and the development of new molecular drugs targeted at airway inflammation and remodeling have become the key and hot points in the prevention and treatment of asthma. Emerging evidence has proven that miRNAs are strongly associated with numerous chronic respiratory diseases including asthma, but the involved molecular mechanisms have not been revealed. In the present study, we successfully isolated exosomes from BMMSCs and found that the derived exosomes could improve airway inflammation and remodeling in ovalbumin-induced asthma rats. Furthermore, we found that the highly expressed miR-223-3p in exosomes might play a key pivotal role in the protective effects on airway remodeling and asthma by regulating the NLRP3-induced ASC/Caspase-1/GSDMD signaling pathway. These results provided a promising molecule candidate and target for the therapy of asthma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, China.
- Department of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, China. Electronic address: yangn39@163.com.
Zitieren
APA
Li, X., & Yang, N. (2023). Exosome miR-223-3p in the bone marrow-derived mesenchymal stem cells alleviates the inflammation and airway remodeling through NLRP3-induced ASC/Caspase-1/GSDMD signaling pathway. International Immunopharmacology, 123, 110746. https://doi.org/10.1016/j.intimp.2023.110746
Vancouver
Li X, Yang N. Exosome miR-223-3p in the bone marrow-derived mesenchymal stem cells alleviates the inflammation and airway remodeling through NLRP3-induced ASC/Caspase-1/GSDMD signaling pathway. International Immunopharmacology. 2023;123:110746. doi:10.1016/j.intimp.2023.110746
BibTeX
@article{Li2023,
author = {Li, Xiang and Yang, Nan},
title = {Exosome miR-223-3p in the bone marrow-derived mesenchymal stem cells alleviates the inflammation and airway remodeling through NLRP3-induced ASC/Caspase-1/GSDMD signaling pathway},
journal = {International Immunopharmacology},
year = {2023},
volume = {123},
pages = {110746},
doi = {10.1016/j.intimp.2023.110746}
}
EUVIMED